Science and Research

Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells

Previously, the expression of a non-secreted IL-4 variant (IL-4delta13) has been described in association with apoptosis and age-dependent Th2 T-cell polarization. Signaling pathways involved in this process have so far not been studied. Here we report the induction of IL-4delta13 expression in human gammadelta T-cells upon treatment with a sublethal dose of histone deacetylase (HDACi) inhibitor valproic acid (VPA). Induction of IL-4delta13 was associated with increased cytoplasmic IL-4Ralpha and decreased IL-4 expression, while mRNA for mature IL-4 was concomitantly down-regulated. Importantly, only the simultaneous combination of apoptosis and necroptosis inhibitors prevented IL-4delta13 expression and completely abrogated VPA-induced global histone H3K9 acetylation mark. Further, our work reveals a novel involvement of transcription factor c-Jun in the signaling network of IL-4, HDAC1, caspase-3 and mixed lineage kinase domain-like protein (MLKL). This study provides novel insights into the effects of epigenetic modulator VPA on human gammadelta T-cell differentiation.

  • Bhat, J.
  • Sosna, J.
  • Fritsch, J.
  • Quabius, E. S.
  • Schutze, S.
  • Zeissig, S.
  • Ammerpohl, O.
  • Adam, D.
  • Kabelitz, D.

Keywords

  • HDAC inhibitors
  • Il-4
  • Immune response
  • Immunity
  • Immunology and Microbiology Section
  • apoptosis
  • necroptosis
  • valproic acid
Publication details
DOI: 10.18632/oncotarget.11462
Journal: Oncotarget
Pages: 64743-64756 
Number: 40
Work Type: Original
Location: ARCN
Disease Area: AA
Partner / Member: UKSH (Kiel)
Access-Number: 27556516
See publication on PubMed

DZL Engagements

chevron-down